Description
This product utilizes Synthetic CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD70 (clone ARGX-1G1G0Z). We employs the pBR322 (SP6-Cy3-PAX-BamHI) vector components and the SynExpress system of the lncRNA Base Editing/Delayed feedback for a robust and sustained response against cancers.
Host
Human
Target
CD70
Clone
ARGX-1G1G0Z
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
Cy3
Promoter
SP6
Effector Gene
PAX
Insertion Sites
BamHI
Gene Modification
Base Editing
Modification Domain
lncRNA
Carrier Type
pBR322
Transformation Accuracy
0.96
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.